Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-05-30

FDA Approved: TESTOSTERONE — Supplemental Application (Prasco Laboratories)

View source ↗

Summary

FDA approved a supplemental application for TESTOSTERONE submitted by Prasco Laboratories. This action approves a modification to the approved NDA 022309 for th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TESTOSTERONE (testosterone)

Snippet

SUPPL AP for TESTOSTERONE (TESTOSTERONE)